Literature DB >> 14560150

Quality of life in patients with functional dyspepsia: a prospective 1-year follow-up study in Spanish patients.

Ana Gutiérrez1, Luis Rodrigo, Sabino Riestra, Eloy Fernández, Valle Cadahia, Rafael Tojo, Dolores Fuentes, Pilar Niño, Jose Luis Olcoz.   

Abstract

BACKGROUND AND AIMS: The natural history of functional dyspepsia is not well known. We prospectively assess the quality of life and severity of symptoms in a group of Spanish patients with functional dyspepsia. PATIENTS AND METHODS: One hundred and twelve consecutive patients with functional dyspepsia, according to Rome II criteria, were prospectively followed up for 1 year. All patients completed symptom (Dyspepsia Questionnaire and the Gastrointestinal Symptoms Rating Scale) and quality of life [the Psychological General Well-Being (PGWB) Index and the General Health Questionnaire (GHQ)] questionnaires every 3 months. Only free antacid consumption was permitted during the study period.
RESULTS: The group was made up of 81 women and 31 men with a mean age of 45 +/- 17 years; 66% of patients were infected with Helicobacter pylori, and ulcer-like dyspepsia (53%) was the predominant subgroup. At baseline, quality of life scores were low (PGWB, 87.1 +/- 17.6 and GHQ, 20.6 +/- 11.8), but these values gradually improved during the year of follow-up (PGWB, 107.7 +/- 1.1 and GHQ, 8.9 +/- 0.4). Digestive symptoms also decreased. In the multivariate analysis, the anxiety score on the PGWB index (Wald, 5.2; P = 0.02) and smoking status (Wald, 4.3; P = 0.04) were predictors of end quality of life. At baseline, patients with a high level of anxiety had a very reduced quality of life, although their symptom scores were similar to other patients.
CONCLUSION: Quality of life is reduced in patients with functional dyspepsia. Some improvement in quality of life together with a decrease in the severity of symptom scores was seen during the 1 year of follow-up. We believe that both the reassurance of negative endoscopy and the scheduling of visits to the doctor favourably influence the quality of life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560150     DOI: 10.1097/00042737-200311000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

2.  The role of diet in the management of non-ulcer dyspepsia.

Authors:  Mohsen Akhondi-Meybodi; Mohammad Ali Aghaei; Zahra Hashemian
Journal:  Middle East J Dig Dis       Date:  2015-01

3.  Smaller CO2 injection volume and lower gastric pressure induce bothersome symptoms in drug-resistant functional dyspepsia patients with less frequent belching.

Authors:  Eri Momma; Saori Kanai; Yoshimasa Hoshikawa; Mai Koeda; Tomohide Tanabe; Shintaro Hoshino; Noriyuki Kawami; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

Review 4.  The role of psychosocial factors and psychiatric disorders in functional dyspepsia.

Authors:  Lukas Van Oudenhove; Qasim Aziz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.